---
title: "Sector Update: Healthcare Stocks Softer Friday Afternoon"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286600357.md"
description: "Healthcare stocks declined on Friday, with the NYSE Healthcare Index down 0.9%. Aardvark Therapeutics shares plummeted 31% after a clinical hold by the FDA. DexCom's shares rose over 6% following new long-term financial goals. ARS Pharmaceuticals and Alumis saw declines of nearly 5% and over 5%, respectively, due to wider losses and significant revenue drops."
datetime: "2026-05-15T17:51:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286600357.md)
  - [en](https://longbridge.com/en/news/286600357.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286600357.md)
---

# Sector Update: Healthcare Stocks Softer Friday Afternoon

01:51 PM EDT, 05/15/2026 (MT Newswires) -- Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index falling 0.9% and the State Street Healthcare Select Sector SPDR ETF (XLV) shedding 0.8%.

The iShares Biotechnology ETF (IBB) dropped 2.5%.

In corporate news, Aardvark Therapeutics ( AARD ) shares fell 31% after the firm said the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101. Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.

DexCom ( DXCM ) said Friday it has set new long-term financial goals, including organic revenue growth of more than 10% a year through 2030. Its shares climbed past 6%.

ARS Pharmaceuticals ( SPRY ) shares fell nearly 5% after it posted a wider Q1 net loss.

Alumis ( ALMS ) stock was down more than 5% after it reported that its Q1 revenue dropped to $1.7 million from $17.4 million a year earlier.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [ALMS.US](https://longbridge.com/en/quote/ALMS.US.md)
- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)
- [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md)
- [AARD.US](https://longbridge.com/en/quote/AARD.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [ARS Pharmaceuticals Q1 revenue beats estimates on neffy sales growth](https://longbridge.com/en/news/286545099.md)
- [BUZZ-Dexcom climbs on plans to revamp board panel](https://longbridge.com/en/news/286583878.md)
- [Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany | DXCM Stock News](https://longbridge.com/en/news/286763500.md)
- [Dexcom Unveils 2030 Targets and $1 Billion Buyback](https://longbridge.com/en/news/286549422.md)
- [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://longbridge.com/en/news/286571686.md)